DATED 10 DECEMBER 2021 SHANGHAI BIO-HEART BIOLOGICAL TECHNOLOGY CO., LTD.上海百心安生物技術股份有限公司 THE CONTROLLING SHAREHOLDER(named in Schedule 1) andHUATAI FINANCIAL HOLDINGS (HONG KONG) LIMITED HONG KONG UNDERWRITING AGREEMENT relating to a public offering...

External Document
AutoNDA by SimpleDocs
Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!